148 related articles for article (PubMed ID: 19794381)
1. Recurrent peptic ulcer disease in a pediatric patient with type 1 neurofibromatosis and primary ciliary dyskinesia.
Lionetti E; Francavilla R; Ruggieri M; Di Stefano V; Principi MB; Pavone L
Minerva Pediatr; 2009 Oct; 61(5):557-9. PubMed ID: 19794381
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
4. Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report.
Lee WS; Koh YS; Kim JC; Park CH; Joo YE; Kim HS; Cho CK; Choi SK; Rew JS; Kim SJ
BMC Cancer; 2005 Jul; 5():85. PubMed ID: 16042772
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term outcomes of surgical management of peptic ulcer complications in the era of proton pump inhibitors.
Hasadia R; Kopelman Y; Olsha O; Alfici R; Ashkenazi I
Eur J Trauma Emerg Surg; 2018 Oct; 44(5):795-801. PubMed ID: 29354867
[TBL] [Abstract][Full Text] [Related]
7. Proton-pump inhibitors for acute peptic ulcer bleeding.
Erstad BL
Ann Pharmacother; 2001 Jun; 35(6):730-40. PubMed ID: 11408992
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole for bleeding PUD: do we finally have evidence for effective medical therapy?
Pedersen PJ; Bjorkman DJ
Am J Gastroenterol; 1998 Sep; 93(9):1583-5. PubMed ID: 9732953
[No Abstract] [Full Text] [Related]
11. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
[TBL] [Abstract][Full Text] [Related]
12. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
Lin HJ; Lo WC; Cheng YC; Perng CL
Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
[TBL] [Abstract][Full Text] [Related]
13. Intravenous proton pump inhibitor therapy: a rationale for use.
Armstrong D
Rev Gastroenterol Disord; 2005; 5 Suppl 2():S18-30. PubMed ID: 16369224
[TBL] [Abstract][Full Text] [Related]
14. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
15. Comparison of omeprazole and placebo for bleeding peptic ulcer.
Srinath C
Trop Gastroenterol; 1997; 18(3):115-6. PubMed ID: 9385855
[No Abstract] [Full Text] [Related]
16. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
17. Intravenous omeprazole after endoscopic treatment of bleeding peptic ulcers.
Palmer KR
Gut; 2001 Nov; 49(5):610-1. PubMed ID: 11600458
[No Abstract] [Full Text] [Related]
18. [Peptic ulcer disease etiology, diagnosis and treatment].
Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
[TBL] [Abstract][Full Text] [Related]
19. Proton-pump inhibitors in peptic ulcer disease.
Chan FK
Lancet; 2008 Oct; 372(9645):1198-200. PubMed ID: 19094939
[No Abstract] [Full Text] [Related]
20. Proton pump inhibitors and recurrent bleeding in peptic ulcer disease.
Tajima A; Koizumi K; Suzuki K; Higashi N; Takahashi M; Shimada T; Terano A; Hiraishi H; Kuwayama H
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S237-41. PubMed ID: 19120905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
